Prognosis of patients with breast cancers up to 1 cm in diameter

European Journal of Cancer

Volumn 32, Issue 3, 1996, Pages 417-420

  Fentiman, I S ^a   Hyland, D ^a   Chaudary, M A ^a   Gregory, W M ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

Axilla; Breast cancer; Screening; Small tumours

Indexed keywords

AGE; ARTICLE; BREAST TUMOR; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LYMPH NODE METASTASIS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SURVIVAL; AXILLARY LYMPH NODE; BREAST CANCER; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUMOR VOLUME;

AGE FACTORS; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 0041374812     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(95)00610-9     Document Type: Article

References (18)

1. Shapiro S, Venet W, Strax P, et al. Ten to fourteen year effect of screening on breast cancer mortality. J Natl Cancer Inst 1982, 69, 349-353.
2. Tabar L, Fagerberg CJG, Gad A, et al. Reduction in mortality from breast cancer after mass screening with mammography. Lancet 1985, i, 829-832.
3. Andersson I, Aspergren K, Janssen L, et al. Mammographic screening and mortality from breast cancer. The Malmo mammographic screening trial. Lancet 1988, 2, 943-948.
4. Frisell J, Eklund G, Hellstrom L, et al. Randomised study of mammographic screening for breast cancer: mortality at seven years. Lancet 1990, 335, 241-246.
5. Haybittle JL, Blarney RW, Elston CW, et al. A prognostic index in primary breast cancer. Br J Cancer 1982, 45, 361-366.
6. O'Reilly SM, Camplejohn RS, Barnes DM, et al. Node negative breast cancer: prognostic sub-groups defined by tumour size and flow cytometry. J Clin Oncol 1990, 8, 2040-2046.
7. Halverson KJ, Taylor ME, Perez CA, et al. Management of the axilla in patients with breast cancers one centimeter or smaller. Am J Clin Oncol (CCT) 1994, 17, 461-466.
8. Sinn HP, Oelmann A, Anton HW, Diel IJ. Metastatic potential of small and minimally invasive breast carcinomas. Virchows Archiv 1994, 425, 237-241.
9. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. Am Stat Assoc J 1958, 53, 457-481.
10. Cox DR. Regression models and life tables. J R Stat Soc (B) 1972, 34, 187-200.
11. Peto R, Pike MC, Armitage P, et al. Design and analysis of clinical trials requiring prolonged observation of each patient: II Analysis and examples. Br J Cancer 1977, 35, 1-39.
12. Pocock SJ. Clinical Trials: A Practical Approach. New York, Wiley, 1984, 143-159.
13. Badwe RA, Gregory WM, Chaudary MA, et al. Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer. Lancet 1991, i, 1261-1264.
14. Fentiman IS, Richards MA, Gregory WM. Effect of menstrual cycle phase on surgical treatment of breast cancer. Lancet 1994, 34, 402.
15. Ahlgren J, Stal O, Westman GM, Arnesson L-G. Prediction of axillary lymph node metastases in a screened breast cancer population. Acta Oncol 1994, 33, 603-608.
16. Ravdin PM, De Laurentis M, Vendely T, Clark GM. Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators. J Natl Cancer Inst 1994, 86, 1771-1775.
17. Axelsson CK, Mouridsen HT, Zedeler K. Axillary dissection of level I and II lymph nodes is important in breast cancer classification. Eur J Cancer 1992, 8/9, 1415-1418.
18. Kiricuta CI, Tausch J. A mathematical model of axillary lymph node involvement based on 1446 complete axillary dissections in patients with breast carcinoma. Cancer 1992, 69, 2496-2501.